"10.1371_journal.pone.0148764","plos one","2016-02-29T00:00:00Z","Gregory N Dietsch; Hailing Lu; Yi Yang; Chihiro Morishima; Laura Q Chow; Mary L Disis; Robert M Hershberg","VentiRx Pharmaceuticals, Seattle, WA, United States of America; Tumor Vaccine Group, Center for Translational Medicine in Womens Health, University of Washington, Seattle, WA, United States of America; Department of Laboratory Medicine, University of Washington, Seattle, WA, United States of America; Department of Medicine, University of Washington, Seattle, WA, United States of America","Conceived and designed the experiments: GD HL CM LC RH MD. Performed the experiments: GD HL YY CM LC. Analyzed the data: GD HL CM. Contributed reagents/materials/analysis tools: GD HL CM. Wrote the paper: GD HL MD.","Gregory N. Dietsch and Robert M. Hershberg are both employees and have ownership (shares) in VentiRx Pharmaceuticals, Seattle, WA, United States of America. Gregory N. Dietsch and Robert M. Hershberg have Patent applications (pending and actual) to which the authors are affiliated and from which the authors may benefit. Robert M. Hershberg is a Board Member of VentiRx Pharmaceuticals. Mary L. Disis is a paid consultant for VentiRx Pharmaceuticals, Seattle, WA, United States of America. The association of Gregory N. Dietsch, Robert M. Hershberg and Mary L. Disis with VentiRx Pharmaceuticals does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","02","Gregory N Dietsch","GND",7,TRUE,6,5,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
